PHARMACORP RX INC (PCRX.CA) Stock Price, Forecast & Analysis

TSX-V:PCRX • CA71714X1050

0.435 CAD
+0.01 (+1.16%)
Last: Feb 18, 2026, 07:00 PM

PCRX.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap75.72M
Revenue(TTM)17.60M
Net Income(TTM)189.60K
Shares174.08M
Float151.01M
52 Week High0.58
52 Week Low0.4
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0
PEN/A
Fwd PEN/A
Earnings (Next)04-20
IPO2022-05-16
Sector
GICS SectorConsumer Staples
GICS IndustryConsumer Staples Distribution & Retail
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS SubIndustryDrug Retail
PCRX.CA short term performance overview.The bars show the price performance of PCRX.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6 -8 -10

PCRX.CA long term performance overview.The bars show the price performance of PCRX.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of PCRX.CA is 0.435 CAD. In the past month the price decreased by -8.42%. In the past year, price decreased by -20.91%.

PHARMACORP RX INC / PCRX Daily stock chart

PCRX.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PCRX.CA. When comparing the yearly performance of all stocks, PCRX.CA is a bad performer in the overall market: 87.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
PCRX.CA Full Technical Analysis Report

PCRX.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PCRX.CA. While PCRX.CA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PCRX.CA Full Fundamental Analysis Report

PCRX.CA Financial Highlights


Industry RankSector Rank
PM (TTM) 1.08%
ROA 0.48%
ROE 0.63%
Debt/Equity 0.13
Chartmill High Growth Momentum
EPS Q2Q%58.14%
Sales Q2Q%334.83%
EPS 1Y (TTM)-5.98%
Revenue 1Y (TTM)N/A
PCRX.CA financials

PCRX.CA Forecast & Estimates

5 analysts have analysed PCRX.CA and the average price target is 0.66 CAD. This implies a price increase of 52.41% is expected in the next year compared to the current price of 0.435.


Analysts
Analysts80
Price Target0.66 (51.72%)
EPS Next YN/A
Revenue Next YearN/A
PCRX.CA Analyst EstimatesPCRX.CA Analyst Ratings

PCRX.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners10.67%
Short Float %N/A
Short RatioN/A
PCRX.CA Ownership

About PCRX.CA

Company Profile

PCRX logo image PharmaCorp Rx, Inc. operates as a capital pool company, which focuses on identifying and evaluating the assets or businesses in the pharmacy industry. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2022-05-16. The firm operates approximately seven PharmaChoice Canada bannered pharmacies in Canada and continues to acquire PharmaChoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The firm also acquires independently owned non-PharmaChoice Canada bannered pharmacies in Canada, and thereafter, continues to operate such acquired pharmacies under a PharmaChoice Canada banner.

Company Info

PHARMACORP RX INC

Suite #203, 303 Wellman Lane

Saskatoon SASKATCHEWAN CA

Employees: 0

PCRX Company Website

Phone: 13065363771

PHARMACORP RX INC / PCRX.CA FAQ

What does PHARMACORP RX INC do?

PharmaCorp Rx, Inc. operates as a capital pool company, which focuses on identifying and evaluating the assets or businesses in the pharmacy industry. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2022-05-16. The firm operates approximately seven PharmaChoice Canada bannered pharmacies in Canada and continues to acquire PharmaChoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The firm also acquires independently owned non-PharmaChoice Canada bannered pharmacies in Canada, and thereafter, continues to operate such acquired pharmacies under a PharmaChoice Canada banner.


What is the current price of PCRX stock?

The current stock price of PCRX.CA is 0.435 CAD. The price increased by 1.16% in the last trading session.


Does PHARMACORP RX INC pay dividends?

PCRX.CA does not pay a dividend.


What is the ChartMill rating of PHARMACORP RX INC stock?

PCRX.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the number of employees for PHARMACORP RX INC?

PHARMACORP RX INC (PCRX.CA) currently has 0 employees.